Jill Ham
Family · Leesburg, VANPI 1164611752
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AstraZeneca at 24.0% of the total. Among family clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $26.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Sanofi$970
- GSK$517
- Genentech USA, Inc.$320
- Pfizer$279
- plus $1K from 17 others
What the payments were for
- Food & beverage$6,32398%
- Education$1552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 70 | $1,557 |
| Regeneron Healthcare Solutions, Inc. | 50 | $1,398 |
| Sanofi | 25 | $970 |
| GSK | 28 | $517 |
| Genentech USA, Inc. | 9 | $320 |
| Pfizer | 7 | $279 |
| AbbVie | 8 | $232 |
| Kaleo, Inc. | 9 | $216 |
| Incyte Corporation | 3 | $170 |
| Sanofi-aventis U.S. LLC | 2 | $155 |
| Boehringer Ingelheim | 5 | $102 |
| CSL Behring | 4 | $92 |
| Novartis | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Teva Pharmaceuticals USA, Inc. | 4 | $75 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $71 |
| Alk-abello, Inc | 2 | $36 |
| Greer Laboratories, Inc. | 1 | $28 |
| Amgen | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Nabriva Therapeutics, PLC | 1 | $20 |
| Optinose US, Inc. | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,478 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $508 |
| Azelastine Hcl | 13 | $494 |
| Montelukast Sodium | 14 | $69 |
Paid to pharmacies, not to this prescriber.
Other family in Leesburg
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.